Additional file 1 of Sero-survey on long-term care facility residents reveals increased risk of sub-optimal antibody response to BNT162b2: implications for breakthrough prevention
COVIDIAGNOSTIX - Health Technology Assessment in Covid serological diagnostics. SARS-COV-2 serologcal results, obtained in serial evaluations at 0,1,3,6 months from the first dose of anti-Sars-CoV-2
The authors analyze NP-antibody dynamics considering individual vaccination status and prior infections to better understand the NP-antibody response to infection in vaccinated and unvaccinated indivi
Immunology Database and Analysis Portal2025-12-18 更新40
aPresented as protected/total number of subjects. bPresented as % protected (95% CI by modified Wald Method). cPresented as median (range) days. d,ep-value calculated by Fisher’s exact test comparing
a Values marked with the same superscripts in the same column were not significantly different (p > 0.05).¶ S.D = standard deviation. The lower limit of detection of the assay used to detect and quant
Antibody levels on the 28th day from the administration of the second dose of vaccine or after COVID-19 recovery, stratified by sex, age and clinical presentation of COVID-19.
